Results 91 to 100 of about 1,091,984 (241)
The American Biology Teacher, 2012 Who are we? The question of human nature seems to haunt all disciplines. That may tell us how very “human” the question is. Answers vary widely. Yet scientists—anthropologists, geneticists, ethologists, and developmental and evolutionary biologists—rely on observations and empirical data. Their conclusions thus seem more objective. Biologically, humans
openaire +1 more source
Design and analysis strategies for robust microbiome ageing research
FEBS Letters, EarlyView.The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
FEBS Letters, EarlyView.CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens +8 more
wiley +1 more source
La reestructuración ideal de las familias migrantes en la ley de extranjería
Athenea Digital, 2013 La articulación legal de los vínculos de parentesco en extranjería se rige por una lógica restrictiva que combina una composición nuclear y dependiente con desajustes en la forma concreta de gestionar las distancias, las dinámicas y los tiempos en origen
Encarnación La Spina
doaj +1 more source
Reconstructing enzyme evolution by protein engineering
FEBS Letters, EarlyView.Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler +2 more
wiley +1 more source
Investigating transcription factor dynamics in health and disease using FRAP
FEBS Letters, EarlyView.FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj +3 more
wiley +1 more source
Mitigation of Human Supervisory Control Wait Times through Automation Strategies [PDF]
, 2005 The application of network centric operations principles to human supervisory control (HSC) domains means that humans are increasingly being asked to manage multiple simultaneous HSC processes. However, increases in the number of available information
Mitchell, P. J. +2 more
core
Nosaltres, els humans: principalment uns microbis [PDF]
, 2020 Els humans tenen menys gens heretats dels progenitors que no pas gens del conjunt de bacteris beneficiosos que habiten el propi ...
Berlanga Herranz, Mercedes +1 more
core +1 more source
Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
FEBS Letters, EarlyView.Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta +3 more
wiley +1 more source
Structure‐forward targeting of claudins with synthetic binders
FEBS Letters, EarlyView.Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley +1 more source